Centessa Pharmaceuticals plc Investors: Please contact the Portnoy Law Firm to recover your losses; Last days to actively participate in the case; November 28, 2022 LOS ANGELES, Oct. 20, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Centessa Pharmaceuticals plc (“Centessa” or the “Company”) (NASDAQ: CNTA) that a class action has been filed on behalf of...

Centessa Pharmaceuticals plc (CNTA) Class Action Notice: If You Incurred Significant Losses in Centessa Pharmaceuticals plc Contact Robbins LLP for Information About Your Rights SAN DIEGO, Oct. 19, 2022 (GLOBE NEWSWIRE) -- The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that...

Centessa Pharmaceuticals plc Equity Notice: Centessa Pharmaceuticals plc (CNTA) Shareholders with Significant Losses Should Contact Robbins LLP for Information About their Rights SAN DIEGO, Oct. 13, 2022 (GLOBE NEWSWIRE) -- The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that...

Centessa Pharmaceuticals plc Shareholder Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Centessa Pharmaceuticals plc (CNTA) SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities...

Centessa Pharmaceutical plc Investors: Company Investigated by the Portnoy Law Firm Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Centessa Pharmaceutical plc...